Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009) - Wikidata - wikimedia - TriplyDB

Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009)

Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009)

http://www.wikidata.org/entity/Q33933879

about

"Stormy waters ahead": global emergence of carbapenemases Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden Threat Avibactam and Class C -Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance Clinical management of infections caused by multidrug-resistant Enterobacteriaceae Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.Carbapenem Resistance among Enterobacter Species in a Tertiary Care Hospital in Central India.Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio Global incidence of carbapenemase-producing Escherichia coli ST131.Identification and characterization of the first Escherichia coli strain carrying NDM-1 gene in China.The world's microbiology laboratories can be a global microbial sensor network.Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance Current epidemiology and growing resistance of gram-negative pathogens.Multidrug-resistant (MDR) Klebsiella pneumoniae clinical isolates: a zone of high heterogeneity (HHZ) as a tool for epidemiological studies Outbreak of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan in 2011.Surveillance of Australian Hajj pilgrims for carriage of potentially pathogenic bacteria: Data from two pilot studies Occurrence of blaNDM-₁ & absence of blaKPC genes encoding carbapenem resistance in uropathogens from a tertiary care centre from north India.Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America.Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model OXA-181 Beta Lactamase is not a Major Mediator of Carbapenem Resistance in Enterobacteriaceae.Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase.Spread of carbapenemase NDM-1 producers: the situation in India and what may be proposed.OXA-48-like carbapenemases: the phantom menace.The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae.Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.Adjuvant immunotherapies as a novel approach to bacterial infections.A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011.The spread and acquisition of NDM-1: a multifactorial problem.OXA β-lactamases.Multidrug-resistant Escherichia coli in Asia: epidemiology and management.Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade.Tackling antimicrobial resistance in lower urinary tract infections: treatment options.Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.Widespread Dissemination of Carbapenem-Resistant Escherichia coli Sequence Type 167 Strains Harboring blaNDM-5 in Clinical Settings in China Rapid Screening for Carbapenem Resistant Organisms: Current Results and Future Approaches

P2860

Q21131125-6627F46C-518D-489B-B397-26F54A40F871 Q26751295-74B55AF9-59F7-4248-851C-1EACBDDBE5DE Q27684678-87333A09-F150-4E34-B47D-F7CAFD67F5AE Q28246841-E3059CCE-8D58-4B38-B71C-990910A946F1 Q30148824-462F37B9-6D27-45CC-BBDF-7A1F5EC1CBC2 Q30234957-8A25327F-D4CC-46EE-B1A4-ECD318026735 Q33798238-76DDA7F1-738C-4045-A4BF-07633F192EA0 Q34080525-5FA3AF9E-AF0A-4DEA-A852-E214652744F2 Q34298956-081E73EB-CE7D-4B0A-AC3D-A2FF3B010C86 Q34426812-74FA59CA-53D5-436C-84F8-C09ACA673BF1 Q34770698-A10B9B7E-6A3A-4A33-AEFD-2B82EEF74E1A Q35091026-64272E6F-EF93-4BDF-85F9-03F9B0053027 Q35167183-5F910F4A-4341-4DB4-A379-3976CFA50374 Q35681590-124CCA6A-BAF6-451B-81A2-0FD19DA90691 Q36025192-DC047E83-88D4-4984-B49D-21A39EFF4C6C Q36040776-E6758FF9-327E-49FA-AE0D-23B3A7C895DB Q36276831-A2240DA7-D3FC-4D65-B639-0EBA09EFEBC2 Q36326260-EB184EAB-267E-4B1D-8E5D-B1133FA4B4C8 Q36347441-76EF1F0C-7DC5-4F61-9521-AE7E81B449F4 Q36402480-B673AE0A-192F-4C73-B9AB-7A49B700FC29 Q36505545-454A6FE5-4ACD-4831-ACB2-88D2725E4578 Q36887866-B43F9E52-E27E-4B1F-8D28-F19D0D904DD3 Q36969763-1F10D799-564B-4B71-B029-9B6529E80213 Q37036574-FEF7945D-CC46-47E1-AA47-7179045340B0 Q37258892-ED77163D-AF66-4487-A709-B6643E6D6EA6 Q37340068-A028EB05-11C2-4E54-A217-4D5C0E534074 Q38002060-4A8B65F5-0ACB-47BE-A165-85CFA6BD6C5F Q38002399-F0AEBE1F-AFE6-47FD-BEAA-FA57A4A5DF1A Q38017141-63C09F7B-1747-47E4-892D-40686B575F6F Q38063968-8C95AAC0-C450-493B-A3FC-E8C586E600E5 Q38096056-DC25943F-4BF0-452D-BCD2-F9BED40B25FA Q38167246-B5723CAA-DEA6-48BB-A76E-B5971525339B Q38168928-E9851995-8160-4563-89C9-07EDABEBE4F5 Q38201699-BA1395E0-07C1-4F4C-91E7-525D6C479AC6 Q38389612-68592EC9-6E30-4485-A11B-E17B8E3982EB Q38430967-2CC514CB-68B9-4157-9318-6F689B4C8B3B Q38833839-1691A90C-FC80-4A79-9F33-2759742D2CD9 Q38842620-C80DB14D-6E6C-42A9-B381-C0C482B89C67 Q38875986-0E067424-CCFA-4952-B5B8-4B6D6B403F72 Q38949947-0B6A8D15-1A86-4EB4-BD79-0288FDB7087C

P2860

Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009)

http://www.wikidata.org/entity/Q33933879

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Increasing prevalence and diss ...... ta from the SMART study (2009)

@ast

Increasing prevalence and diss ...... ta from the SMART study (2009)

@en

type

label

Increasing prevalence and diss ...... ta from the SMART study (2009)

@ast

Increasing prevalence and diss ...... ta from the SMART study (2009)

@en

prefLabel

Increasing prevalence and diss ...... ta from the SMART study (2009)

@ast

Increasing prevalence and diss ...... ta from the SMART study (2009)

@en

P1433

Q33933879-7D94B3F2-F665-4785-942C-62610E30FDE4

P1476

Q33933879-84B1377D-E01A-4717-95C4-13C7BC40A490

P2093

Q33933879-15992907-5D9F-456A-95C3-A8465A541D60

Q33933879-1B130F0C-AE62-43BD-B3B5-DE4D48788445

Q33933879-42595CB6-0F8C-422E-A5ED-49BD58E75965

Q33933879-447254EC-E2E5-4532-8A5D-BB6D82A55BE2

Q33933879-68D28853-B2C9-46DE-AB94-B39D08616A7A

Q33933879-823F9D88-3974-4B26-8F7B-10EB4461B2AD

P2860

Q33933879-034B55AF-AE61-4895-BA40-1E61F7AA89B5

Q33933879-0576864D-82DB-4211-8513-D1E7A8A8CB39

Q33933879-1219E2DE-FCBE-408E-99CB-3FA15AEE658A

Q33933879-124D8825-D31A-4E5B-9888-56E10E750D8F

Q33933879-24B7591F-F5C2-46BC-874B-C35043EB5A7B

Q33933879-25CE5EB4-6B9A-47C5-8024-0D60B0F0ECEC

Q33933879-38B12ADA-E6A4-4F75-973C-90E72D3B3731

Q33933879-4B31DB46-5EE7-40BE-AB08-AD7E4617C7BB

Q33933879-5348FBDF-30D4-4FD4-A7D3-19E8FAD00865

Q33933879-5D6C45E5-5415-4726-9E08-3663AA99D4CF

P304

Q33933879-90CA058F-0A39-4736-8926-A29A679E4DE2

P31

Q33933879-9A14FA40-DA37-4DC5-8223-D63874B4EC41

P356

Q33933879-76E61C28-E366-41B1-9C2A-755B0BD71889

P407

Q33933879-D04B125A-15A5-4602-85EB-B148B248DD61

P433

Q33933879-57AE720E-60C4-4B27-8CDD-2C12768FD067

P478

Q33933879-CDF409D5-1385-4AA3-A793-774F02663DCB

P50

Q33933879-65CBF8BB-F9FF-43E2-B581-403D2775479C

Q33933879-ACD5BE97-3865-4489-96AA-313F3188620E

P577

Q33933879-DDE3FACF-0A29-4749-85C0-0664F980D5B0

P5875

Q33933879-9EAA0B36-44F6-406F-A9D1-481263C84B2F

P698

Q33933879-B56F66B6-E625-42B7-854D-5F1D77B96932

P921

Q33933879-89C5D266-A52A-4720-B31F-561F71AB98B2

P932

Q33933879-839D1B9D-2D0F-434C-A813-FC304194222E

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Increasing prevalence and diss ...... ta from the SMART study (2009)

@en

P2093

Christine Lascols

http://www.w3.org/2001/XMLSchema#string

Daryl Hoban

http://www.w3.org/2001/XMLSchema#string

Meredith Hackel

http://www.w3.org/2001/XMLSchema#string

Robert Badal

http://www.w3.org/2001/XMLSchema#string

Sam Bouchillon

http://www.w3.org/2001/XMLSchema#string

Steven H Marshall

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-spectrum beta-lactamases: a clinical update

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.

New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.

NDM-1--a cause for worldwide concern.

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility.

NDM-2 carbapenemase in Acinetobacter baumannii from Egypt.

P304

1992-1997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKR240

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Robert A Bonomo

P577

2011-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51222664

http://www.w3.org/2001/XMLSchema#string

P698

21676902

http://www.w3.org/2001/XMLSchema#string

P921

P932

3153502

http://www.w3.org/2001/XMLSchema#string